Edit |   |
---|---|
Antigenic Specificity | Naltrexone |
Clone | polyclonal |
Host Species | Sheep |
Reactive Species | n/a |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | >5mg/ml (U.V.abs @ 280nm) |
Applications | ELISA (EIA), Western Blot (WB), Dot Blot (DB), Immunohistochemistry (IHC), Immunoassays, Development of Rapid tests and Other Immunoassay, Antibody Recognition Assays |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. It is marketed in generic form as its hydrochloride salt, naltrexone hydrochloride, and marketed under the trade names Revia and Depade. Naltrexone and its active metabolite 6-beta-naltrexol are competitive antagonists at |- and beta-opioid receptors, and to a lesser extent at beta-opioid receptors.[1] The plasma half-life of naltrexone is about 4 h, for 6-beta-naltrexol 13 h. The blockade of opioid receptors is the basis behind its action in the management of opioid dependence - it reversibly blocks or attenuates the effects of opioids. Its use in alcohol (ethanol) dependence has been studied and has been shown to be ef |
Immunogen | Immunogen: Naltrexone-BTG |
Other Names | n/a |
Gene, Accession # | n/a |
Catalog # | MBS340532 |
Price | please inquire |
Order / More Info | Naltrexone Antibody from MYBIOSOURCE INC. |
Product Specific References | 1. Shader, RI. Antagonists, Inverse Agonists, and Protagonists. Journal of Clinical Psychopharmacology. 2003 Aug; 23(4):321?322. PMID 12920406 |